Loading...
XNAS
BKYI
Market cap5mUSD
Jul 09, Last price  
5.01USD
1D
-5.67%
1Q
-11.48%
Jan 2017
-99.87%
Name

BIO-Key International Inc

Chart & Performance

D1W1MN
XNAS:BKYI chart
P/E
P/S
0.89
EPS
Div Yield, %
Shrs. gr., 5y
72.77%
Rev. gr., 5y
16.53%
Revenues
6m
-12.04%
15,193,6259,988,45612,876,0472,357,2823,520,4083,508,8043,835,8931,985,9764,005,8565,261,2252,975,7566,302,9844,044,5422,267,5282,836,7825,114,4897,020,2587,754,9056,929,5716,095,117
Net income
-5m
L+6.74%
-11,080,851-1,057,224119,1794,693,549-306,789-1,897,6063,267-2,582,151-1,883,572-1,857,306-4,189,704-4,275,338-6,868,875-14,588,700-9,673,987-5,065,781-11,909,903-8,521,837-4,300,692-4,590,370
CFO
-5m
L+60.01%
-3,551,455-2,161,217129,173-1,654,716-312,930-523,11165,552-2,683,911-2,502,927-15,560,088-4,446,830-2,465,462-1,613,475-1,850,347-4,950,108-8,978,428-6,229,034-3,793,456-2,914,072-4,662,921
Dividend
Jul 25, 19970.1111 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
IPO date
Apr 17, 1997
Employees
51
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT